BACKGROUND/OBJECTIVES: Subjects with type 2 diabetes (T2D) and their nondiabetic first-degree relatives (REL) have increased risk of cardiovascular disease (CVD). Postprandial triglyceridemia (PPL), influenced by diet, is an independent risk factor for CVD. Dietary fat elicits increased PPL in T2D compared with nondiabetic controls, but our knowledge of PPL responses to fat in REL is sparse. Our aim was to test the hypothesis that REL respond to a monounsaturated fatty acid (MUFA) challenge with a higher PPL response compared with controls who have no family history of T2D (CON) and that MUFAs exert a differential impact on incretin responses and on the expression of genes involved in carbohydrate and lipid metabolism in muscle and adipose tissues of REL and CON. SUBJECTS/METHODS: A total of 17 REL and 17 CON consumed a meal with 72 energy percent derived from MUFAs (macadamia nut oil). Plasma triglycerides, free fatty acids, insulin, glucose, glucagon-like peptide 1, glucose-dependent insulintropic peptide and ghrelin were measured at baseline and regular intervals until 4 h postprandially. Muscle and adipose tissue biopsies were collected at baseline and at 210 min after the meal. RESULTS: The MUFA-rich meal did not elicit different responses (P>0.05) in PPL, insulin, glucose, incretins or ghrelin in REL and CON. Several genes were differentially regulated in muscle and adipose tissues of REL and CON. CONCLUSIONS: A MUFA-rich meal elicits similar PPL, insulin and incretin responses in REL and CON. MUFAs have a differential impact on gene expression in muscle and adipose tissues in a pattern pointing toward early defects in lipid metabolism in REL.
INTRODUCTION
Type 2 diabetes (T2D) is associated with increased mortality from cardiovascular diseases (CVD). Also, nondiabetic first-degree relatives of subjects with T2D (REL) have a high risk of CVD. 1 Besides established risk factors, increased postprandial triglyceridemia (PPL) is an independent risk factor for CVD in T2D 2 and nondiabetic subjects. 3 PPL is modulated by diet with the major determinants being the amount and quality of fat and carbohydrate. 4 Thus, PPL responses in both healthy 5 and T2D subjects 6 are higher to a meal rich in saturated fatty acids (SFAs) than to a meal rich in monounsaturated fat (MUFAs). Interestingly, an exaggerated and prolonged PPL response has been demonstrated in T2D. 7 Our knowledge of PPL in REL is still sparse, for example, we do not know whether a meal rich in MUFAs causes similar PPL responses in REL as in nondiabetic controls with no family history of T2D (CON). In acute studies, mixed-fat meals have provided higher [8] [9] [10] [11] or similar [12] [13] [14] PPL in REL as in CON. Recently, we demonstrated that a meal high in medium-chain SFAs resulted in a higher PPL response in REL compared with that in CON. 15 As REL have a substantial predisposition for, although they do not yet express, the metabolic disturbances of T2D, they constitute a good model for studying early pathophysiological aberrations leading to T2D, for example, different gene expression responses to severe stimuli. In the present study, we hypothesize that a meal rich in MUFAs causes a higher PPL response in REL compared with CON and exerts a differential impact on circulating incretins and on expression of genes regulating lipid and carbohydrate metabolism in muscle and adipose tissues.
MATERIALS AND METHODS Subjects
Seventeen first-degree REL and 17 CON participated in the study. REL had at least two first-degree relatives with T2D or past history of gestational diabetes and one relative with T2D. The screening characteristics (Table 1) and the study design have been reported previously. 15 Fasting plasma glucose of the subjects was o7.1 mmol/l at screening. Thirteen REL and 10 CON had fasting plasma glucose of 5.6-7.0 mmol/l. None of the subjects had any medical conditions or received any medications that could interfere with the outcome of the study. Three REL and two CON were treated with oral lipid-lowering drugs. The subjects did not smoke or have any history of alcohol abuse.
The study was performed in accordance with the Declaration of Helsinki, 6th revision (2008) and approved by the local Ethical Committee (Region Midtjylland, Denmark). All subjects gave their written consent to participate in the study.
Study design
Clinical and biochemical characteristics of the subjects were measured at screening. For 48 h before the test meal, the subjects refrained from strenuous physical activity. For 24 h preceding the test meal, the participants refrained from alcohol and ingested a standard diet (delivered from the research unit) with an energy content of 7000 kJ (1672 kcal) for women and 9000 kJ (2150 kcal) for men. A total of 56 energy % (E%) was from carbohydrate, 24 E% from fat and 20 E% from protein. The test meals were served after an 8-h fast and ingested within 15 min. Muscle and adipose tissue biopsies were collected at baseline and at 210 min after the meal. Blood samples were drawn at baseline, 15, 30, 60, 120, 180 and 240 min after the test meal.
Test meal
The MUFA-rich test meal consisted of 40 g of white bread, 400 ml of tap water and a soup made of 150 ml of chicken broth, 10 ml of lime juice, 10 g of leek, 2.5 g of curry powder and 80 g of macadamia nut oil (SpiZe, Zelected Foods A/S, Nyborg, Denmark). We have chosen macadamia nut oil, a vegetable oil with one of the highest relative amounts of monounsaturated fat, which has not previously been studied in relatives or healthy subjects. The macronutrient composition and energy content of the meal is given in Table 2 . Fatty acid composition of macadamia nut oil as reported by the producer was: 9% palmitic acid (C16:0), 20% palmitoleic acid (C16:1), 4% stearic acid (C18:0), 60% oleic acid (C18:1), 3% linoleic acid (C18:2), 2% arachidic acid (C20:0) and 2% gadoleic acid (C20:1).
Blood analyses
Screening blood samples were analyzed on the day of collection at the central laboratory (Aarhus University Hospital). On meal test days, plasma samples were immediately separated by centrifugation at 2000x gravity for 15 min at 4°C. The samples were placed in a -20°C freezer for 24 h and the next day were stored in a -80°C freezer until analyses were performed.
Plasma triglycerides (TGs) were measured with a lipoprotein lipasebased colorimetric assay using a TG GPO-PAP kit (Roche/Hitachi Diagnostics, Mannheim, Germany) with intra-assay coefficient of variation (CV) 1.5% and inter-assay CV 1.8%. Serum insulin was measured with an ELISA Insulin kit (Dako, Glostrup, Denmark) with intra-assay CV 7.5% and inter-assay CV 9.3%. Plasma glucose was measured by a glucose oxidase method with a Glucose GOD-PAP kit (Roche/Hitachi Diagnostics) with intra-assay CV 0.9% and inter-assay CV 1.8%. Plasma-free fatty acids (FFAs) were measured by an acyl-CoA synthetase-based colorimetric assay using a FFA-HR(2) ACS-ACOD kit (Waco Chemicals GmbH, Neuss, Germany) with combined intra-and inter-assay CV 1.5%. Total plasma glucagon-like peptide-1 (GLP-1) concentrations were measured against standards of synthetic GLP-1 7-36 amide using antiserum code no. 89390, which is specific for the C-terminal of the GLP-1 molecule and reacts equally with the intact GLP-1 and the primary metabolite GLP-1, 9-36 amide. The intraassay CV was o 6% and the inter-assay CV o 15%. Active plasma glucosedependent insulinotropic polypeptide (GIP) was measured using antiserum code no. 98171, which is specific for the N-terminal of the GIP molecule (GIP 1-10) and reacts with the intact active GIP. 16 The intra-assay CV was o6% and the inter-assay CV o15%. Total plasma ghrelin was measured with a radioimmunoassay kit (Millipore, St Charles, MO, USA) with intra-assay CVo10.0% and inter-assay CVo 18.0%. All quality controls were within predefined limits.
Biopsies
Biopsies were collected at baseline and at 210 min from the lateral vastus muscle and from abdominal subcutaneous adipose tissue with Bergström's needle under local analgesia with Lidocaine 20 mg/ml (SAD, Amgros I/S, Copenhagen, Denmark). The biopsies were blotted for blood, snap-frozen in liquid nitrogen and stored in a -80°C freezer until analyses were performed.
We have chosen to perform the postprandial biopsies at 210 min on the basis of a study in which muscle biopsies collected at 180 min postprandially already showed a differential gene expression in REL and CON. 13 By choosing the time point of 210 min we aimed at improving the chance of detecting both fast and slower gene expression changes.
Gene expression analyses
RNA was isolated from 25 mg of muscle tissue and 250 mg of adipose tissue using an acid guanidinium thicyanate-phenol-chloroform extraction method (Trizol Reagent 15596-018, Invitrogen, Life Technologies, Carlsbad, CA, USA). Gene expression analyses were performed by AROS Applied Biotechnology AS, Denmark, using a real-time qPCR system (BioMark, Fluidigm, San Francisco, CA, USA). Premade primers and TaqMan Gene Expression Assay probes were purchased from Applied Biosystems (Life Technologies). The cycle threshold values were measured in duplicate and normalized to the geometric mean of the reference genes β-actin and β2-microglobulin. Baseline expression of reference genes was not statistically different between groups and was not altered in response to the test meal. Correction for the remaining variation in expression of reference genes was performed using the Pfaffl method. We identified a number of genes earlier shown to be differentially expressed in response to a fat-rich meal in patients with T2D, nondiabetic controls and in a very few studies of REL. A few additional genes were chosen on the basis of the results of a mixed-fat study carried out in REL. 13 The investigated genes were involved in lipid and carbohydrate metabolism and are listed in Table 3 .
Statistical analyses and calculations
Power calculations were performed on the primary end point plasma TGs using the data from an earlier postprandial study in REL, in which the mean plasma TGs were 1.3 mmol/l, standard error of measurement was 0.6 mmol/l and the calculated minimal sample size to obtain a significance of 0.05 and a power of 0.80 with a minimal relevant difference of 0.20 was 16.6 persons. 13 Thus, we included 17 subjects in each arm of the study. Comparisons between groups were performed using the two-tailed Student's t-test or the Mann − Whitney rank-sum test. Comparisons within groups were performed using the paired t-test or Wilcoxon signed-rank test. Concentrations of circulating substances after the test meal were compared using repeated measurements analysis of variance adjusting for baseline values, age, gender, body mass index and total body fat percentage. The responses to the test meal were also analyzed as 4-h areas under the curve (AUCs) calculated using common geometrical rules and reported as incremental AUCs (iAUCs), except for FFAs and ghrelin that decreased after the meal. For FFAs, AUCs are reported as total AUCs, as baseline values were close to similar. For ghrelin, AUCs are reported as decremental AUC, as baseline values were different. Changes in gene expression in response to the test meal are reported as percent change from baseline. The problem of multiple statistical testing was addressed by using the False Discovery Rate correction. 17 When data were normally distributed, results were reported as mean and 95% confidence interval. When data were logarithm transformed, results were reported as median and 95% confidence interval, and when a nonparametrical test was used, as median and the interquartile range. For visual purposes, all curves are depicted using mean ± s.e.m. A probability value (P)o0.05 was considered statistically significant. All statistical calculations were performed using the statistical program STATA version 10.1 and SigmaPlot11.0.
RESULTS
All participants ingested the test meal and had blood samples collected. Three subjects refused an adipose tissue biopsy and three subjects refused a muscle biopsy. For those subjects, tissue obtained from the completed biopsies was withdrawn from the analyses. Baseline concentrations of TGs, FFAs, insulin, glucose, GLP-1, GIP and ghrelin were not statistically different between REL and CON.
Plasma triglyceride, FFAs, glucose and serum insulin Although similar fasting TGs (P = 0.959) and TG iAUCs (Table 4 ; P = 0.630) were obtained, mean TG responses (assessed as timeΧgroup in a repeated measurements analysis of variance model and adjusted for baseline, age, gender, body mass index and total body fat percentage) differed significantly (P = 0.005) between REL and CON ( Figure 1a) . The mean-adjusted FFAs (Figure 1b) , glucose ( Figure 1c ) and insulin (Figure 1d ) responses, also assessed as timeΧgroup, did not differ between REL and CON (P = 0.257, 0.090 and 0.258, respectively). Similarly, FFA, insulin and glucose AUCs were comparable between REL and CON (Table 4 ).
Plasma GLP-1, GIP and ghrelin We did not observe differences in mean GLP-1 responses (assessed with repeated measurements analysis of variance and adjusted for baseline, age, gender, body mass index and total body fat percentage) (P = 0.948) (Figure 1e ), GIP responses (P = 0.439) (Figure 1f ) or ghrelin responses (P = 0.479) (data not shown) between REL and CON. Similar GLP-1, GIP and ghrelin AUCs were detected in the two groups (Table 4) . Gene expression In muscle, several genes were upregulated in CON in response to the MUFA-rich meal (Figures 2a-c) : CD36, UCP3, PNPLA2 and NR1H3. In adipose tissue, UCP3, PIK3R1, PRKCD, PRKCQ, HK2 and PPARGC1A were upregulated in response to the meal in CON, whereas PDP1 was upregulated in REL (Figures 2d-f) . The changes from baseline to 210 min in expression of ACSL1 and PRKCD in adipose tissue did not reach significance within groups, but differed significantly between REL and CON ( Figures  2d and e) .
DISCUSSION
In the present study, we compared the acute effects of a MUFA-rich meal of macadamia nut oil on PPL, incretin and ghrelin responses in REL with those in CON, as well as on expression of selected transcription factors and genes involved in lipid and glucose metabolism in muscle and adipose tissues. Incorporation of nuts may improve the overall nutritional quality of the diet 18 and reduce the risk of major cardiovascular end points. 19 Interestingly, the effect on PPL of this refined nut oil with one of the highest contents of MUFAs has not previously been studied in relatives or healthy subjects. Thus, we have chosen to evaluate the effects of macademia nut oil on PPL. Secondly, the composition and amount of fat in the test meal is according to the recommendations for oral fattolerance tests, that is, we included >75 g of fat in the test meal and performed blood sampling and measurements for 4 h postprandially. 3 Our study did not confirm our hypothesis that a MUFA-rich meal causes a higher PPL response in REL compared with that in CON. However, a MUFA-rich meal exerts a differential impact on expression of genes involved in lipid metabolism in adipose tissue and muscle of REL and CON in a pattern pointing toward early defects in lipid metabolism in REL.
Although similar values of fasting TGs and TG iAUCs to the MUFA-rich meal were found, the mean TG response curves differed between REL and CON. Initially, REL exhibited a lower TG response compared with CON, but after approximately 180 min the TG response in REL surpassed that in CON. We do not know whether a longer observation period would have revealed a delayed and increased TG response in REL as observed in T2D. 3 Acute studies on mixed-fat meals (MUFAs and SFAs) have shown similar 9, [12] [13] [14] or higher TG responses in REL compared with CON. 8, [10] [11] Previously, we found that medium-chain SFAs elicit increased TG iAUCs in REL, which was not the case in the present study on MUFAs. In line with our results, Thomsen et al. 5, 6 found higher 8-h TG iAUC responses to SFAs, but not to MUFAs, in T2D compared with healthy subjects. Circulating FFAs, glucose and insulin responses did not differ between groups, which corroborates our recent study on medium-chain SFAs 15 and most previous acute studies on PPL responses to mixed-fat meals in REL. [11] [12] [13] [14] In the present study, incretin and ghrelin responses did not differ between groups. This is in agreement with our study on medium-chain SFAs, 15 although others have found a higher GIP response to a mixed meal 20 and reduced fasting ghrelin in REL. 21 The capacity for post-absorptive lipid oxidation is diminished in insulin resistance resulting in intramyocellular lipid deposition, while rates of lipolysis in adipose tissue are increased leading to elevated FFA levels. Lipid metabolism is regulated by numerous genes. After the MUFA-rich meal, we found upregulated CD36, a sarcolemmal and mitochondrial long-chain FA transporter, 22 in the muscles of CON, which points toward a relatively compromised postprandial FA transport in REL. This corroborates with the finding of an impaired expression of CD36 in muscles of REL after a mixed-fat meal. 13 ACSL1, which converts long-chain FA into acylCoA and thus activates FA for esterification or oxidation, tended to be upregulated in adipose tissue of CON and downregulated in REL in response to the test meal. The difference in ACSL1 expression reached statistical significance. ACSL1 expression in adipose tissue is positively correlated to insulin sensitivity, 23 indicating that the blunted postprandial upregulation of ACSL1 may have a role for compromised FA storage in REL. In muscles of CON, we found upregulated PNPLA2 after the MUFA-rich meal. Baseline PNPLA2 protein content in muscles is found to be comparable in healthy and T2D subjects, although no studies on postprandial PNPLA2 expression in muscle tissue have been reported. As PNPLA2 hydrolyzes myocellular TG stores rendering FA for oxidation, upregulation of PNPLA2 during fasting or exercise is appropriate. 24 It is, however, puzzling that PNPLA2 was upregulated after a high-fat meal providing a surplus of FA. The MUFA-rich meal caused upregulation of UCP3, a mitochondrial carrier involved in FA oxidation and protection from reactive oxygen species, 25 in muscle and adipose tissues of CON, but not in REL. Previously, we found upregulated UCP3 in muscles of CON, but not REL, in response to medium-chain SFAs. No other studies on postprandial UCP3 expression in T2D or REL are available; however, reduced baseline UCP3 expression is found in adipose tissues 26 and in the muscles of T2D 27 patients. A blunted postprandial upregulation of UCP3 in REL may have a role for compromised FA oxidation.
Genes involved in carbohydrate metabolism, that is, PIK3R, PRKCD, PRKCQ and HK2 were upregulated following a MUFA-rich meal in the adipose tissues of CON but not in REL. Conversely, PDP1 was upregulated in adipose tissue of REL. PRKCD mRNA has not been detectable in adipocytes in a previous study 28 and PRKCD and PRKCQ were very sparsely expressed in adipose tissue in our study, indicating a limited importance. Similar to observations in T2D, 29 we a found lower expression of PIK3R, the regulatory subunit of phosphatidylinositol 3-kinase, in adipose tissues of REL. MUFAs did not elicit any differences in regulation of SLC2A4 and IRS1, as did medium-chain SFAs in our previous study.
15 HK2 phosphorylates glucose, thereby directing it for glycolysis, glucose oxidation or glycogen storage. 30 Insulinstimulated HK2 expression is decreased in adipose tissue in T2D, but not in REL. 29 In CON, but not REL, we found postprandial upregulation of HK2 in adipose tissue, which may have a minor role in compromised glucose metabolism in REL. PDP1 activates the pyruvate dehydrogenase complex, directing pyruvate from the glycolytic pathway to the citric acid cycle or fatty acid synthesis; pyruvate dehydrogenase complex is deactivated by FA oxidation. 31 We found that the MUFA-rich meal elicited an upregulation of PDP1 in the adipose tissue of REL, which was unexpected due to the low carbohydrate content and the surplus lipid supply of the MUFA-rich meal.
PPARG is a key transcription factor orchestrating several metabolic pathways inducing FA uptake and oxidation, as well as mitochondrial biogenesis.
32 PPARGC1A activates transcription of PPARG. In adipose tissue, baseline PPARGC1A expression is found increased in T2D, 26 although others have found decreased mRNA and protein content in insulin-resistant subjects. 33 We observed similar basal PPARGC1A expression in REL and CON. Yet, PPARGC1A was significantly upregulated after the meal in adipose tissues of CON only, which may indicate an early transcriptional defect in REL, when challenged with a MUFA-rich meal.
In conclusion, the present study did not confirm our hypothesis that a MUFA-rich meal causes an increased PPL response in REL. However, a MUFA-rich meal exerts a differential impact on expression of genes involved in lipid metabolism in adipose tissue and muscle in a pattern pointing toward early defects in lipid metabolism in REL.
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